Medxy AI

Silk-Hyaluronic Acid Laryngoplasty: Evaluating Safety and Efficacy in Treating Glottic Insufficiency

By MedXY 10/12/2026

Silk-hyaluronic acid injection laryngoplasty offers a safe, effective office-based treatment for glottic insufficiency, showing comparable voice improvement to hyaluronic acid alone but with higher rates of operative revisions.

General Surgery Infectious Diseases news

Reevaluating Postoperative Antibiotic Use After Appendectomy in Acute Appendicitis: Insights from a Large Retrospective Study

By MedXY 10/12/2026

A large retrospective study shows no benefit of routine postoperative antibiotics after appendectomy for acute appendicitis, even with intra-abdominal fluid; highlights risk factors driving infections instead.

news OB/GYN & Women's Health

Reducing Multiple Pregnancies After IVF: Practical Guidance from RCOG Scientific Impact Paper No.22 (3rd Ed., 2026)

By MedXY 10/12/2026

The RCOG 2026 update stresses single embryo transfer, improved freezing, counselling and funding to prevent IVF multiple pregnancy and its harms while maintaining live-birth rates.

Gastroenterology news Pediatrics

Outcomes and Mortality After Pediatric First Variceal Hemorrhage: Insights from a Global Multicenter Study

By MedXY 10/12/2026

This international multicenter study reveals low immediate mortality after pediatric first variceal hemorrhage, with outcomes strongly influenced by underlying diagnosis, disease severity, and center-specific practices.

Neurology news

Physical Activity and Motor and Cognitive Progression in Parkinson Disease: A Longitudinal Cohort Study

By MedXY 10/12/2026

This study links higher physical activity levels with slower cognitive and motor decline in Parkinson's disease, highlighting the importance of sustained activity engagement.

Diabetes & Endocrinology news

Integrating Polygenic Risk Scores and Lifestyle Factors to Predict Type 2 Diabetes Onset in the Japanese Population

By MedXY 10/12/2026

This study demonstrates that polygenic risk scores (PRS) independently predict type 2 diabetes risk in Japanese individuals, and healthy lifestyles can mitigate this risk even among genetically predisposed people, enhancing personalized prevention strategies.

Neurology news Rehabilitation Medicine

Impact of OTC Analgesics on Concussion Recovery: Insights from the CARE Consortium Study

By MedXY 10/12/2026

Over-the-counter analgesic use after concussion is linked to reduced symptom severity and faster return to unrestricted play, highlighting their potential role in postconcussion management.

Neurology news Public Health

High Burden of Fall-Related Injuries Among Stroke Survivors in Ethiopia: Insights from a Multicenter Study in Amhara Region

By MedXY 10/12/2026

A 2024 multicenter study in Amhara, Ethiopia found nearly 80% of stroke survivors experienced fall-related injuries, with older age, rural residency, and walking/turning activities as key risk factors.

news Otorhinolaryngology Pathology & Lab Medicine

Immune Profiling in Oral Tongue Dysplasia: Identifying Biomarkers to Stratify High-Risk Patients

By MedXY 10/12/2026

This study identifies immune biomarkers, including proliferative CD8+ T cells, CD68+ macrophages, and PD-1 expression, which differentiate high-risk oral tongue epithelial dysplasia and may improve patient risk stratification beyond conventional histology.

news Ophthalmology

Advancing Vision: Optogenetic Therapy Offers Hope for Retinitis Pigmentosa Patients

By MedXY 10/12/2026

An open-label trial demonstrates the safety and potential efficacy of ChrimsonR-based optogenetic therapy combined with specialized goggles to enhance light sensitivity in patients with advanced retinitis pigmentosa, offering promising avenues for restoring visual function.

Hematology-Oncology news

Prognostic Significance of Telomere Length in Chronic Lymphocytic Leukemia Under Venetoclax-Based First-Line Therapy

By MedXY 10/11/2026

Telomere length serves as an independent prognostic marker for progression-free survival in chronic lymphocytic leukemia patients treated with venetoclax-based regimens, highlighting its role in risk stratification during the modern targeted therapy era.

Hematology-Oncology news Oncology

High Efficacy and Safety of Glofitamab Plus Polatuzumab-R-CHP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Multicenter Study

By MedXY 10/11/2026

A phase II trial shows that adding the bispecific antibody glofitamab to polatuzumab-R-CHP achieves a 95% complete response rate and durable remission with minimal cytokine release syndrome in high-risk diffuse large B-cell lymphoma.

$Efficacy and Safety of Ziftomenib Combined with Venetoclax and Azacitidine in Relapsed/Refractory NPM1-Mutated Acute Myeloid Leukemia$

Hematology-Oncology news Oncology

Efficacy and Safety of Ziftomenib Combined with Venetoclax and Azacitidine in Relapsed/Refractory NPM1-Mutated Acute Myeloid Leukemia

By MedXY 10/11/2026

This article reviews the KOMET-007 trial evaluating ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated AML, highlighting promising remission rates and manageable safety.

Critical Care news

Optimizing ICU Pharmacist Workload: Impact on Patient Mortality and Medication Management

By MedXY 10/11/2026

This study identifies higher pharmacist-to-patient ratios and interruptions in comprehensive medication management as key contributors to increased mortality among ICU patients, highlighting the need for optimized pharmacist staffing in critical care.

Allergy & Immunology news Respiratory

Trajectory of Exacerbations in Biologic-Eligible Severe Asthma: Insights from UK Nationwide Data

By MedXY 10/11/2026

A large UK study reveals that over two-thirds of biologic-eligible severe asthma patients improve without biologic therapy, identifying distinct exacerbation trajectories linked to blood eosinophil levels and disease phenotype.

Cardiology news Pediatrics

Sotatercept as Add-On Therapy in Pediatric Pulmonary Hypertension: Promising Outcomes from the Pediatric Pulmonary Hypertension Network

By MedXY 10/11/2026

Retrospective multi-center data demonstrate that sotatercept improves functional status, exercise capacity, and hemodynamics in children with pulmonary hypertension, with a manageable safety profile.

news Pediatrics Respiratory

Lung Health after Preterm Birth: Practical Consensus for Lifelong Respiratory Care

By MedXY 10/11/2026

An expert consensus from the BPD Collaborative outlines pragmatic, lifespan-focused recommendations to identify, monitor, and manage prematurity-associated lung disease (PLD) and to standardize outpatient care from infancy through adulthood.

Clinical Updates news Respiratory

Gut Microbiota and Idiopathic Pulmonary Fibrosis: Associations with Disease Severity and Survival Outcomes

By MedXY 10/11/2026

Emerging evidence reveals gut microbiota profiles correlate with disease severity and survival in idiopathic pulmonary fibrosis, highlighting potential microbial biomarkers and treatment modifiers.

news Respiratory

Age-Adjusted Whole Genome Sequencing Telomere Length in Idiopathic Pulmonary Fibrosis: Enhancing Diagnostic and Prognostic Precision

By MedXY 10/11/2026

Age-adjusted WGS-estimated telomere length improves identification of pathologically short telomeres and detection of telomere-related variants in IPF, associating with survival outcomes but offering limited survival prediction beyond clinical variables.

Cardiology news Ophthalmology

PCSK9 Inhibitors and Their Protective Role Against Retinal Vascular Occlusions in Hyperlipidemic Patients

By MedXY 10/11/2026

PCSK9 inhibitors significantly reduce the risk of retinal vascular occlusions compared to other lipid-lowering therapies in patients with hyperlipidemia, highlighting their potential as a neuroprotective cardiovascular intervention.